XELJANZ
Identification of Xeljanz
| No description |
Google image searchProduct monograph
Active ingredient
tofacitinib (tofacitinib citrate), 5 MG
DIN: 02423898
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 03-JUN-2014
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AF — Janus-associated kinase (JAK) inhibitors (ATC, ATC/DDD)
- L04AF01 — TOFACITINIB (ATC/DDD)
